Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-024695
Filing Date
2018-04-11
Accepted
2018-04-11 20:00:39
Documents
1
Period of Report
2018-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5922
  Complete submission text file 0001209191-18-024695.txt   7209
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
USMAN NASSIM (Reporting) CIK: 0001206872 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 18751001